NZ286834A - Treatments using a dual carrier immunogenic construct vaccine of a primary carrier molecule less than 70KD conjugated to a secondary carrier comprising A T-dependent antigen
- Google Patents
Treatments using a dual carrier immunogenic construct vaccine of a primary carrier molecule less than 70KD conjugated to a secondary carrier comprising A T-dependent antigen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jackson H M Found Military MedfiledCriticalJackson H M Found Military Med
Publication of NZ286834ApublicationCriticalpatent/NZ286834A/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
This dual carrier immunogenic construct for use in a vaccine comprises; a)at least one primary carrier of greater than 70kDa Mr; b) at least one secondary carrier comprising a T-dependent antigen conjugated to a primary carrier; and c) a pharmaceutically acceptable carrier.
NZ286834A1992-02-111996-06-18Treatments using a dual carrier immunogenic construct vaccine of a primary carrier molecule less than 70KD conjugated to a secondary carrier comprising A T-dependent antigen
NZ286834A
(en)
Treatments using a dual carrier immunogenic construct vaccine of a primary carrier molecule less than 70KD conjugated to a secondary carrier comprising A T-dependent antigen
Treatments using a dual carrier immunogenic construct vaccine of a primary carrier molecule less than 70KD conjugated to a secondary carrier comprising A T-dependent antigen